SA
PBYI icon

Sanctuary Advisors’s Puma Biotechnology PBYI Stock Holding History

Sanctuary Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23,866
Closed -$127K – 2540
2025
Q3 		$127K Buy
+23,866
New +$101K ﹤0.01% 2321

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sanctuary Advisors's PBYI Position: Q4 2025 in Review

Sanctuary Advisors sold out of Puma Biotechnology (PBYI) in Q4 2025, closing a stake of 23,866 shares — an estimated $127K sold.

Sanctuary Advisors first reported a position in PBYI in Q3 2025 and held it in 1 quarter. The position peaked at $127K in Q3 2025. 151 funds tracked by Wall St. Rank hold PBYI as of Q4 2025.

  • Sanctuary Advisors reported no remaining Puma Biotechnology position as of Q4 2025 after selling out during the quarter.
  • Sanctuary Advisors sold 23,866 Puma Biotechnology shares in Q4 2025, an estimated $127K.
  • Sanctuary Advisors first reported a position in Puma Biotechnology in Q3 2025 and held it in 1 quarter.
  • Sanctuary Advisors's Puma Biotechnology position peaked at $127K in Q3 2025.
  • 151 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2025.

Based on Sanctuary Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.